CBD Life Sciences, Inc. (CBDL)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
CBD Life Sciences Debt to Equity Ratio : -0.0122 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0122 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.0241 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1666 |
| December 31, 2019 | 0.1553 |
| September 30, 2019 | 0.1969 |
| June 30, 2019 | 0.1716 |
| March 31, 2019 | 0.16 |
| December 31, 2018 | 3.956 |
| September 30, 2018 | 0.0341 |
| June 30, 2018 | 0.0601 |
| March 31, 2018 | 0.0543 |
| December 31, 2017 | 0.0652 |
| September 30, 2017 | -15.87 |
| June 30, 2017 | 0.1584 |
| March 31, 2017 | 0.2443 |
| December 31, 2016 | 2.162 |
| September 30, 2016 | 2.469 |
| June 30, 2016 | 2.134 |
| March 31, 2016 | 1.806 |
| December 31, 2015 | 1.615 |
| September 30, 2015 | 1.440 |
| June 30, 2015 | 1.305 |
| March 31, 2015 | 1.156 |
| December 31, 2014 | -42.85 |
| September 30, 2014 | -3.600 |
| June 30, 2014 | 1.276 |
| March 31, 2014 | 0.58 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ashland, Inc. | 0.7893 |
| Achieve Life Sciences, Inc. | -1.018 |
| BioAdaptives, Inc. | -0.297 |
| BellRing Brands, Inc. | -2.43 |
| Aspire-Lakewood Holdings, Inc. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.5179M |
| Total Liabilities (Quarterly) | -0.0402M |
| Shareholders Equity (Quarterly) | 0.5581M |
| Current Ratio | -15.43 |
| Net Debt Paydown Yield | 0.07% |